A Leadership Team Ready to Launch

Kfir Umansky, Ph.D.

Founder & Director, Research

Read full bio

Kfir Umansky, Ph.D.

Founder & Director, Research

Kfir Umansky, Ph.D. is a seasoned scientist and former faculty member of the Weizmann Institute of Science (WIS). He is the former COO and founder of a translational oncology research center, bringing a wealth of experience in advancing cancer research. Dr. Umansky earned his Ph.D. from the Weizmann Institute of Science.

Isaac Bright, MD

Chief Executive Officer

Read full bio

Isaac Bright, MD

Chief Executive Officer

Dr. Isaac Bright is a seasoned physician-entrepreneur with over 20 years of experience building and investing in life science companies. With more than a decade of Founder and C-suite experience, Dr. Isaac Bright has a strong track-record leveraging medical expertise and business acumen to drive early-stage companies to clinic and/or market. Isaac earned his MD from Stanford University School of Medicine and was a Howard E. Mitchell Fellow at The Wharton School.

Elad Tzahor, Ph.D.

Founder

Read full bio

Elad Tzahor, Ph.D.

Founder

Elad Tzahor, Ph.D. is a distinguished Full Professor at the Weizmann Institute of Science (WIS), where he has been a leading figure in the field of cardiac regeneration for over 20 years. With a Ph.D. from WIS and post-doctoral training at Harvard Medical School, Dr. Tzahor has established themselves as a thought leader in cardiac regenerative medicine, producing a seminal body of work that has significantly advanced the field. Throughout their illustrious career, Dr. Tzahor has been the recipient of numerous prestigious grants and awards, recognizing their groundbreaking research and contributions to cardiovascular science.

Our leadership team brings over 70 years of cumulative experience in advancing early-stage technologies. With a proven track record of success, we have successfully closed transactions, exceeding $3 billion.

This is a headline that spans three lines stacked vertically

“Quote from Isaac about the science and / or company mission.”

Isaac Bright, MD, CEO